Epidemiology, responses, and way forward: The silent epidemic of viral hepatitis and HIV coinfection in Vietnam

Journal of the International Association of Physicians in AIDS Care

Volumn 11, Issue 5, 2012, Pages 311-320

  Sereno, Leandro ^a,b   Mesquita, Fabio ^a   Kato, Masaya ^a   Jacka, David ^a   Van Nguyen, Thi Thuy ^a   Nguyen, Thien Nga ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b HOSPITAL HELIÓPOLIS   (Brazil)

Author keywords

developing countries; hepatitis B virus; hepatitis C virus; HIV coinfection; injecting drug use

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ALCOHOL CONSUMPTION; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; LIVER DISEASE; LIVER TOXICITY; MALE HOMOSEXUAL; MIXED INFECTION; PRIORITY JOURNAL; PROSTITUTION; SYSTEMATIC REVIEW; VIET NAM; VIRUS LOAD;

ANTIBODIES, VIRAL; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PREVALENCE; SEX WORKERS; SUBSTANCE ABUSE, INTRAVENOUS; VIETNAM;

EID: 84867030274     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109712453939     Document Type: Article

References (90)

1. Sixty-Third World Health Assemby Provisional Agenda Item(11.12, A63/15). Geneva, Switzerland: World Health Organization ; 2010 :
2. Combatting the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. Washington DC: United States Department of Health and Human Services ; 2011 :
3. Sixty-Second World Health Assembly Provisional Agenda Item (12.17, A62/22). Geneva, Switzerland: World Health Organization ; 2009 :
4. Hoang B, Simonneau M, Le Xuan P, Audat F, Guichoux P, Jaulmes B. Prevalence of hepatitis B viral markers in Vietnamese blood donors. [Article in French]. Rev Fr Transfus Immunohématol. 1985 ; 28 (3). 227-236
5. Nakata S, Song P, Duc DD, et al. Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. J Gastroenterol Hepatol. 1994 ; 9 (4). 416-419
6. Song P, Duc DD, Hien B, et al. Markers of hepatitis C and B virus infections among blood donors in Ho Chi Minh City and Hanoi, Vietnam. Clin Diagn Lab Immunol. 1994 ; 1 (14). 413-418
7. Katelaris PH, Robertson G, Bradbury R, Tippett G, Hoa DQ, Ngu MC. Seroprevalence of hepatitis viruses in children in rural Viet Nam. Trans R Soc Trop Med Hyg. 1995 ; 89 (5). 487
8. Corwin AL, Dai TC, Duc DD, et al. Acute viral hepatitis in Hanoi, Viet Nam. Trans R Soc Trop Med Hyg. 1996 ; 90 (6). 647-648
9. Kakumu S, Sato K, Morishita T, et al. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam. J Med Virol. 1998 ; 54 (4). 243-248
10. Hipgrave DB, Nguyen TV, Vu MH, et al. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am J Trop Med Hyg. 2003 ; 69 (3). 288-294
11. Tran HT-T, Ushijima H, Quang VX, et al. Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatol Res. 2003 ; 26 (4). 275-280
12. Hanoi, Vietnam: International Conference On Aids ; 2004 :
13. Nguyen VT, McLaws ML, Dore GJ. Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol. 2007 ; 22 (12). 2093-2100
14. Dunford L, Nguyen T, Trinh Q, et al. Epidemiology of blood-borne viruses in Vietnam. 2008 ;:
15. Duong TH, Nguyen PH, Henley K, Peters M. Risk factors for hepatitis B infection in rural Vietnam. Asian Pac J Cancer Prev. 2009 ; 10 (1). 97-102
16. Kallman JB, Tran S, Arsalla A, et al. Vietnamese community screening for hepatitis B virus and hepatitis C virus. J Viral Hepat. 2011 ; 18 (1). 70-76
17. Hinh ND. International epidemiological collaborative surveillance, epidemiology and prevention of HBV, HCV, HIV and rabies at the greater Mekong sub-region. 2010 ;: 1-66
18. Quan VM, Go VF, Nam LV, et al. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study. AIDS Care. 2009 ; 21 (1). 7-16
19. Clatts MC, Colón-López V, Giang LM, Goldsamt La. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health. 2010 ; 87 (2). 278-291
20. Hepatitis c and human immunodeficiency virus infections in injecting drug users in drug treatment centers in vietnam. 2009 ;:
21. Report Rapid Assessment and Response on situation of drug use, HIV/AIDS and inter-sectorial collaboration in Harm Reduction Intervention. HIV/AIDS Asia Regional Program in Vietnam: ; 2011 :
22. Nguyen VT. Hepatitis B infection in Vietnam: current issues and future challenges. Asia Pac J Public Health. 2012 Mar ; 24 (2). 361-73
23. Nguyen CH, Ishizaki A, Chung PTT, et al. Prevalence of HBV infection among different HIV-risk groups in Hai Phong, Vietnam. J Med Virol. 2011 ; 83 (3). 399-404
24. Taylor VM, Choe JH, Yasui Y, Li L, Burke N, Jackson JC. Hepatitis B awareness, testing, and knowledge among Vietnamese American men and women. J Community Health. 2005 ; 30 (6). 477-490
25. Skinhøj P, Aldershvile J, Kjersem M, Black F. Hepatitis B infection in Vietnamese families. J Med Virol. 1983 ; 11 (2). 125-129
26. Taylor VM, Yasui Y, Burke N, Choe JH, Acorda E, Jackson JC. Hepatitis B knowledge and testing among Vietnamese-American women. Ethn Dis. 2005 ; 15 (4). 761-767
27. Nguyen VT, McLaws ML, Dore GJ. Prevalence and risk factors for hepatitis C infection in rural north Vietnam. Hepatol Int. 2007 ; 1 (3). 387-393
28. Miller Ma, Pisani E. The cost of unsafe injections. Bull World Health Organ. 1999 ; 77 (10). 808-811
29. Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int. 2004 ; 19 (1). 95-103
30. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ. 1999 ; 77 (10). 801-807
31. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005 ; 5 (9). 558-567
32. Blood Safety and Availability. Facts and Figures from the 2007 Blood Safety Survey. Fact sheet N°279. World Health Organization: ; 2009 :
33. Ungass Report: Reporting Period: January 2008-December 2009. 2010;2001 :
34. Bank TW Vietnam Regional Blood Transfusion Centers Project Report. The World Bank: ; 2010 :
35. Aids. Ministry of Health: Viet Nam Authority of HIV/AIDS Control ; 2011 :
36. Mellor J, Walsh EA, Prescott LE, et al. Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol. 1996 ; 34 (2). 417-423
37. Nguyen NH, Vutien P, Trinh HN, et al. Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans. Hepatol Int. 2010 ; 4 (2). 523-529
38. Fung J, Lai CL, Hung I, et al. Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin. J Infect Dis. 2008 ; 198 (6). 808-812
39. Pham DA, Leuangwutiwong P, Jittmittraphap A, et al. High prevalence of Hepatitis C virus genotype 6 in Vietnam. Asian Pac J Allergy Immunol. 2009 ; 27 (2-3). 153-160
40. Tokita H, Okamoto H, Tsuda F, et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci U S A. 1994 ; 91 (23). 11022-11026
41. Anh PTH, Duc NB. The situation with cancer control in Vietnam. Jpn J Clin Oncol. 2002 ; 32 (suppl). S92 - S97
42. Nguyen VT, Law MG, Dore GJ. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int. 2008 ; 28 (4). 525-531
43. Ngo AD, Rao C, Hoa NP, Adair T, Chuc NT. Mortality patterns in Vietnam, 2006: Findings from a national verbal autopsy survey. BMC Res Notes. 2010 ; 3: 78
44. Ngoan LT, Lua NT, Hang LTM. Cancer mortality pattern in Viet Nam. Asian Pac J Cancer Prev. 2007 ; 8 (4). 535-538
45. Nguyen TT, Tran KL, Bui NL, Vos T, Ngo DA, Nguyen TH. Viet Nam: Hanoi ; 2010 :
46. International Narcotics Control Strategy Report Volume I Drug and Chemical Control. United States Department of State Bureau for International Narcotics and Law Enforcement Affairs ; 2011 :
47. Results from the HIV/STI Integrated Biological and Behavioral Surveillance (IBBS) in Vietnam 2005-2006. Ministry of Health of Vietnam: ; 2006 :
48. UNGASS Report: Reporting Period: January 2008-December 2009. The Socialist Republic of Vietnam ; 2010 :
49. Brewer DD, Khan AA. HCV and HIV prevalences strongly correlated in Asian communities with reservoirs of HIV in high-risk groups. J Infect Dev Ctries. 2010 ; 4 (7). 442-447
50. HIV, HBV and HCV prevalence estimates: a survey of injecting drug users in bac kan, hoa binh and tuyen quang. HIV/AIDS Asia Regional Project in Vietnam ; 2011 :
51. Thuy NT, Nhung VT, Thuc NV, Lien TX, Khiem HB. HIV infection and risk factors among female sex workers in southern Vietnam. AIDS. 1998 ; 12: 425-432
52. O'Farrell N, Anh M, Thuong N, Nhung V, Tuan N, Long N. Variation in HIV prevalence in female sex workers in An Giang, Vietnam: what is a representative sample?. Int Conf AIDS. 2004 ;:
53. Tran TN, Detels R, Long HT, Van Phung L, Lan HP. HIV infection and risk characteristics among female sex workers in Hanoi, Vietnam. J Acquir Immune Defic Syndr. 2005 ; 39: 581
54. Colby D, Minh TT, Toan TT. Down on the farm: homosexual behaviour, HIV risk and HIV prevalence in rural communities in Khanh Hoa province, Vietnam. Sex Trans Infect. 2008 ; 84: 439-443
55. Nguyen TA, Nguyen HT, Le GT, Detels R. Prevalence and risk factors associated with HIV infection among men having sex with men in Ho Chi Minh City, Vietnam. AIDS Behav. 2008 ; 12: 476-82
56. HIV/STI Integrated Behavioral and Biological Surveillance in Vietnam, IBBS Round II 2009. Hanoi, Vietnam: National Institute of Hygiene and Epidemiology ; 2010 :
57. Wiersma ST, McMahon B, Pawlotsky J-M, et al. Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus. Liver Int. 2011 ; 31 (6). 755-761
58. Hepatitis B Surface Antigen Assays: Operational Characteristics Report 1. 2001 ;:
59. Hepatitis B Surface Antigen Assays: Operational Characteristics Report 2. 2004 ;:
60. Weinbaum CM, Mast EE, Ward JW. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology. 2009 ; 49 (5 suppl). S35 - S44
61. Interpretation of Hepatitis B Serologic Test Results. Atlanta, USA: Centers for Disease Control and Prevention ; 2005 :
62. Gitlin N. Hepatitis B: diagnosis, prevention, and treatment. Clin Chem. 1997 ; 43 ((8 pt 2)). 1500-1506
63. Hepatitis B, World Health Organization, Department of Communicable Diseases Surveillance and Response. 2002 :
64. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol. 2009 ; 50 (2). 227-242
65. Protocolo Clínico e Diretrizes Terapêuticas para o Tratamento da Hepatite Viral Crônica B e Coinfecções. 2010 ;:
66. Testing and Public Health Management of Persons with Chronic Hepatitis B Virus. Atlanta, USA: Centers for Disease Control and Prevention ; 2010 :
67. Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009 ; 50 (3). 661-662
68. McCaughan GW, Omata M, Amarapurkar D, et al. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol. 2007 ; 22 (5). 615-633
69. I Consenso da Sociedade Brasileira de Infectologia para o Manuseio e Terapia da Hepatite C. São Paulo, Brazil: Sociedade Brasileira de Infectologia ; 2009 :
70. Consenso sobre condutas nas hepatites virais b e c. São Paulo, Brazil: Sociedade Brasileira de Hepatologia ; 2005 :
71. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009 ; 49 (4). 1335-1374
72. Araújo ESA, Mendonça JS, Barone AA, et al. Consensus of the Brazilian Society of Infectious Diseases on the management and treatment of hepatitis C. Braz J Infect Dis. 2007 ; 11 (5). 446-450
73. Liaw YF, Leung N, Kao JH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008 ; 2 (3). 263-283
74. Bedossa P. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy. Liver Int. 2009 ; 29 (suppl 1). 19-22
75. Halfon P, Bourlière M, Pénaranda G, Cacoub P. Les marqueurs sanguins non invasifs de fibrose hépatique au cours de l'infection chronique par le virus de l'hépatite C. Rev Méd Interne. 2006 ; 27 (10). 751-761
76. Bourliere M, Penaranda G, Ouzan D, et al. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients. Aliment Pharmacol Ther. 2008 ; 28 (4). 458-467
77. Marcellin P, Ziol M, Bedossa P, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009 ; 29 (2). 242-247
78. Ogawa E, Furusyo N, Toyoda K, et al. Transient elastography for patients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis. Hepatol Res. 2007 ; 37 (12). 1002-1010
79. Becker L, Salameh W, Sferruzza A, et al. Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States. Clin Gastroenterol Hepatol. 2009 ; 7 (6). 696-701
80. Adams La, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005 ; 51 (10). 1867-1873
81. Borsoi Viana MS, Takei K, Collarile Yamaguti DC, Guz B, Strauss E. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. Ann Hepatol. 2009 ; 8 (1). 26-31
82. Calès P, Boursier J, Oberti F, et al. FibroMeters: a family of blood tests for liver fibrosis. Gastroentérol Clin Biol. 2008 ; 32 (6 suppl 1). 40-51
83. Calès P, Halfon P, Batisse D, et al. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. J Hepatol. 2010 ; 53 (2). 238-244
84. Abenavoli L, Addolorato G, Riccardi L, Gasbarrini A, Gasbarrini G, Rapaccini GL. Elastography assessment in patients with chronic HCV infection. Int J Clin Pract. 2008 ; 62 (7). 1108-1112
85. Benhamou Y. Antiretroviral therapy and HIV/hepatitis B virus coinfection. Clin Infect Dis. 2004 ; 38 (suppl 2). S98 - S103
86. Rapti IN, Hadziyannis SJ. Treatment of special populations with chronic hepatitis B infection. Expert Rev Gastroenterol Hepatol. 2011 ; 5 (3). 323-339
87. Soriano V, Barreiro P, Nuñez M. Management of chronic hepatitis B and C in HIV-coinfected patients. J Antimicrob Chemother. 2006 ; 57 (5). 815-818
88. Eramova I, Matic S, Munz M. HIV/AIDS Treatment and Care: Clinical Protocols for the WHO European Region. Copenhagen, Denmark: World Health Organization Regional Office for Europe ; 2007 :
89. Yu ML, Chuang WL. Treatment of chronic hepatitis C in Asia: when East meets West. J Gastroenterol Hepatol. 2009 ; 24 (3). 336-345
90. Matthews GV, Dore GJ. HIV and hepatitis C coinfection. J Gastroenterol Hepatol. 2008 ; 23 (7 pt 1). 1000-1008